Mayne Pharma Group Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	2016 - 2020
Cash & Equivalents	59.84	110.07	92.62	96.67	97.98	Upgrade
Short-Term Investments	40.56	39.21	127.53	-	-	Upgrade
Trading Asset Securities	-	-	-	1.33	-	Upgrade
Cash & Short-Term Investments	100.4	149.28	220.14	98.01	97.98	Upgrade
Cash Growth	-32.74%	-32.19%	124.62%	0.03%	-28.89%	Upgrade
Accounts Receivable	164.62	176.47	177.4	259.72	175.83	Upgrade
Other Receivables	17.28	31.21	32.12	23.3	17.51	Upgrade
Receivables	181.9	207.68	209.52	283.02	193.34	Upgrade
Inventory	50.56	74.63	82.7	108.91	102.51	Upgrade
Prepaid Expenses	16.37	19.2	13.1	11.57	8.85	Upgrade
Restricted Cash	2.37	2.32	9.1	0.41	0.37	Upgrade
Other Current Assets	1.19	7.49	19.08	9.71	13.48	Upgrade
Total Current Assets	352.79	460.59	553.63	511.62	416.53	Upgrade
Property, Plant & Equipment	58.87	53.33	51.48	225.86	221.6	Upgrade
Goodwill	-	-	-	22.13	59.54	Upgrade
Other Intangible Assets	542.11	567.86	615.23	396.32	1,068	Upgrade
Long-Term Deferred Tax Assets	41.76	45.34	22.66	118.49	172.21	Upgrade
Long-Term Deferred Charges	3.67	0.72	2.04	9.07	-491.28	Upgrade
Other Long-Term Assets	15.41	15.34	2.32	4.45	16.7	Upgrade
Total Assets	1,015	1,143	1,247	1,288	1,463	Upgrade
Accounts Payable	30.25	20.87	32.03	63.57	42.36	Upgrade
Accrued Expenses	140.41	179.85	195.87	113.19	63.78	Upgrade
Short-Term Debt	-	-	10.81	405.37	51.16	Upgrade
Current Portion of Long-Term Debt	35.15	31.64	-	-	1.08	Upgrade
Current Portion of Leases	3.46	3.82	3.62	2.63	2.89	Upgrade
Current Income Taxes Payable	-	-	-	1.22	-	Upgrade
Other Current Liabilities	51.73	109.39	68.64	43.33	61.26	Upgrade
Total Current Liabilities	261.01	345.58	310.96	629.31	222.53	Upgrade
Long-Term Debt	-	-	28.48	-	285.8	Upgrade
Long-Term Leases	2.66	3.36	4.6	5.67	6.97	Upgrade
Long-Term Deferred Tax Liabilities	8.8	7.35	7.8	6.03	13.46	Upgrade
Other Long-Term Liabilities	371.4	332.37	260.86	108.4	162.19	Upgrade
Total Liabilities	644.32	688.99	612.99	749.7	691.61	Upgrade
Common Stock	1,226	1,224	1,234	1,239	1,239	Upgrade
Retained Earnings	-1,041	-944	-769.77	-840.35	-559.06	Upgrade
Comprehensive Income & Other	185.29	173.97	170.44	147.7	88.88	Upgrade
Total Common Equity	370.28	454.19	634.36	545.88	768.36	Upgrade
Minority Interest	-	-	-	-7.65	3.22	Upgrade
Shareholders' Equity	370.28	454.19	634.36	538.23	771.58	Upgrade
Total Liabilities & Equity	1,015	1,143	1,247	1,288	1,463	Upgrade
Total Debt	41.27	38.82	47.51	413.67	347.9	Upgrade
Net Cash (Debt)	59.13	110.46	172.64	-315.66	-249.92	Upgrade
Net Cash Growth	-46.47%	-36.02%	-	-	-	Upgrade
Net Cash Per Share	0.75	1.39	2.10	-3.84	-3.18	Upgrade
Filing Date Shares Outstanding	81.25	81.25	83.42	88.24	88.24	Upgrade
Total Common Shares Outstanding	81.25	81.25	83.42	88.24	88.24	Upgrade
Working Capital	91.78	115.01	242.67	-117.69	194	Upgrade
Book Value Per Share	4.56	5.59	7.60	6.19	8.71	Upgrade
Tangible Book Value	-171.82	-113.67	19.14	127.44	-359.08	Upgrade
Tangible Book Value Per Share	-2.11	-1.40	0.23	1.44	-4.07	Upgrade
Land	2.98	2.98	2.98	8.1	9.17	Upgrade
Buildings	19.92	19.92	19.92	128.95	112.53	Upgrade
Machinery	63.69	60.62	65.59	184.83	166.88	Upgrade
Construction In Progress	14.04	6.63	-0.01	11.18	15.24	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.